1. Malcolm 5, Lau YL, Pembrey ME, Levinsky RJ. Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency;Goodship, J.;Lancet,1988
2. Narrowing the boundaries for X-linked severe combined immunodeficiency (SCIDXI) in Xql 3.1-q2 by linkage and deletion analysis;Puck, J.M.; Stewart, C.C.; Conley, M.E.; Nussbaum, R.L.;Am _7 Hum Genet,1990
3. Delineation of the dystonia-parkinsonism syndrome;Graeber, M.B.; Kupke, K.G.; Muller, U.,1992
4. Physical mapping of 60 DNA markers in the p21. l-q2 1.3 region of the human X chromosome;Lafreniere, R.G.; Brown, C.J.; Powers, V.E.;Genomics,1991
5. mLaeurkraoewmitaranasripslianngtaitniodnonfoaorr cells following thalassaemia allogenic bone demonstrated by immunological, DNA and molecular cytogenetic analysis;Katz, F.; Reeves, B.R.; AlexanderS, Kearney; L, Chessells; J.;BrJ Haematol,1993